CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 195 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $367,955 | -50.9% | 10,883 | -66.1% | 0.00% | – |
| Q2 2023 | $749,155 | -80.4% | 32,125 | -82.3% | 0.00% | -100.0% |
| Q4 2022 | $3,817,388 | -34.7% | 181,867 | -13.8% | 0.00% | -33.3% |
| Q3 2022 | $5,845,000 | +11.1% | 211,026 | +1.7% | 0.00% | +50.0% |
| Q2 2022 | $5,260,000 | +718.0% | 207,423 | +682.6% | 0.00% | – |
| Q1 2022 | $643,000 | +18.2% | 26,505 | -5.0% | 0.00% | – |
| Q4 2021 | $544,000 | -25.6% | 27,903 | -22.5% | 0.00% | – |
| Q3 2021 | $731,000 | -13.6% | 36,021 | -5.1% | 0.00% | – |
| Q2 2021 | $846,000 | +19.7% | 37,946 | +23.1% | 0.00% | – |
| Q1 2021 | $707,000 | -46.3% | 30,836 | -36.7% | 0.00% | -100.0% |
| Q4 2020 | $1,316,000 | +727.7% | 48,737 | +441.6% | 0.00% | – |
| Q3 2020 | $159,000 | -22.1% | 8,998 | -26.2% | 0.00% | – |
| Q2 2020 | $204,000 | +325.0% | 12,195 | +203.7% | 0.00% | – |
| Q1 2020 | $48,000 | -76.2% | 4,016 | -75.8% | 0.00% | – |
| Q4 2019 | $202,000 | -2.4% | 16,628 | +13.4% | 0.00% | – |
| Q3 2019 | $207,000 | +31.0% | 14,659 | +3.2% | 0.00% | – |
| Q2 2019 | $158,000 | +285.4% | 14,201 | +302.6% | 0.00% | – |
| Q1 2019 | $41,000 | -35.9% | 3,527 | -27.0% | 0.00% | – |
| Q4 2018 | $64,000 | +25.5% | 4,831 | +33.1% | 0.00% | – |
| Q3 2018 | $51,000 | -74.6% | 3,629 | -71.7% | 0.00% | – |
| Q2 2018 | $201,000 | -23.6% | 12,802 | -19.8% | 0.00% | – |
| Q1 2018 | $263,000 | -81.4% | 15,965 | -79.6% | 0.00% | -100.0% |
| Q4 2017 | $1,415,000 | +170.0% | 78,310 | +188.3% | 0.00% | – |
| Q3 2017 | $524,000 | +26.9% | 27,161 | -22.2% | 0.00% | – |
| Q2 2017 | $413,000 | +126.9% | 34,931 | +111.2% | 0.00% | – |
| Q1 2017 | $182,000 | +31.9% | 16,542 | 0.0% | 0.00% | – |
| Q4 2016 | $138,000 | +60.5% | 16,542 | +24.8% | 0.00% | – |
| Q3 2016 | $86,000 | -14.0% | 13,254 | -28.1% | 0.00% | – |
| Q2 2016 | $100,000 | -9.9% | 18,424 | -22.6% | 0.00% | – |
| Q1 2016 | $111,000 | -6.7% | 23,803 | 0.0% | 0.00% | – |
| Q4 2015 | $119,000 | +2875.0% | 23,803 | +1689.7% | 0.00% | – |
| Q2 2014 | $4,000 | – | 1,330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |